• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    4D Molecular Therapeutics Inc (NQ: FDMT )

    25.15 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 25.15
    Bid (Size) 24.88 (1)
    Ask (Size) 44.15 (1)
    Prev. Close 25.15
    Today's Range 25.15 - 25.15
    52wk Range 9.440 - 36.25
    Shares Outstanding 42,052,980
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS, Misses Revenue for Q1 2024
    FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +18.35%
    +18.35%
    1 Month
    +1.37%
    +1.37%
    3 Month
    -3.93%
    -3.93%
    6 Month
    +104.31%
    +104.31%
    1 Year
    +39.34%
    +39.34%

    More News

    Read More
    4DMT to Participate in Upcoming Investor Conference
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4DMT Announces Presentations at ARVO 2024 Annual Meeting
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
    Via Benzinga
    What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
    Via Benzinga
    Why Is 4D Molecular (FDMT) Stock Up 85% Today?
    Via InvestorPlace
    To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
    Via Benzinga
    Topics ETFs
    4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
    Via Benzinga
    4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4DMT to Participate in Upcoming Investor Conferences
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4DMT Reports Full Year 2023 Financial Results and Operational Highlights
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials for Fabry Disease Cardiomyopathy at WORLDSymposium™ 2024
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
    Via Benzinga
    Why 4D Molecular Therapeutics (FDMT) Stock Is Diving
    Via Benzinga
    4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
    Via Benzinga
    4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
    From 4D Molecular Therapeutics, Inc.
    Via GlobeNewswire
    Crude Oil Moves Higher; Caterpillar Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Gold Moves Lower; ISM Services PMI Beats Estimates
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    4D Molecular Therapeutics Inc. (NASDAQ: FDMT) Leading the Way in Monday Trading Based on Percentage Gain
    Via Investor Brand Network
    Why Is Eye Disease-Focused 4D Molecular Therapeutics Stock Shooting Higher Today?
    Via Benzinga
    Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.